Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III

Virology

Volumn 403, Issue 1, 2010, Pages 85-91

  Zhang, Shuliu ^a   Bovshik, Evgeniy I ^a   Maillard, Rodrigo ^a   Gromowski, Gregory D ^a   Volk, David E ^a   Schein, Catherine H ^a   Huang, Claire Y H ^c   Gorenstein, David G ^a   Lee, James C ^a   Barrett, Alan D T ^a,b   Beasley, David W C ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Attenuation; Envelope protein; Flavivirus; Neutralization; Receptor binding domain; West Nile virus

Indexed keywords

VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; DENGUE VIRUS 2; FEMALE; FLAVIVIRUS; HUMAN; HUMAN CELL; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; WEST NILE FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; FEMALE; HUMANS; MICE; MICROBIAL VIABILITY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT; WEST NILE VIRUS;

FLAVIVIRUS; TICK-BORNE FLAVIVIRUS; WEST NILE VIRUS;

EID: 77953291917     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.03.038     Document Type: Article

References (41)

1. Beasley D.W., Barrett A.D. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J. Virol. 2002, 76(24):13097-13100.
2. Beasley D.W., Li L., Suderman M.T., Barrett A.D. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002, 296(1):17-23.
3. Beasley D.W., Whiteman M.C., Zhang S., Huang C.Y., Schneider B.S., Smith D.R., Gromowski G.D., Higgs S., Kinney R.M., Barrett A.D. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 west nile virus strains. J. Virol. 2005, 79(13):8339-8347.
4. Chin J.F., Chu J.J., Ng M.L. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes Infect. 2007, 9(1):1-6.
5. Choi K.S., Nah J.J., Ko Y.J., Kim Y.J., Joo Y.S. The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization. Virus Res. 2007, 123(2):216-218.
6. Chu J.J., Rajamanonmani R., Li J., Bhuvanakantham R., Lescar J., Ng M.L. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J. Gen. Virol. 2005, 86(Pt 2):405-412.
7. Fraczkiewicz R., Braun W. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J. Comp. Chem. 1998, 19:319-333.
8. Gaunt M.W., Sall A.A., de Lamballerie X., Falconar A.K., Dzhivanian T.I., Gould E.A. Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J. Gen. Virol. 2001, 82(Pt 8):1867-1876.
9. Gentry M.K., Henchal E.A., McCown J.M., Brandt W.E., Dalrymple J.M. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am. J. Trop. Med. Hyg. 1982, 31(3 Pt 1):548-555.
10. Grard G., Moureau G., Charrel R., Holmes E.C., Gould E., de Lamballerie X. Genomics and evolution of Aedes-borne flaviviruses. J. Gen. Virol. 2009.
11. Grard G., Moureau G., Charrel R.N., Lemasson J.J., Gonzalez J.P., Gallian P., Gritsun T.S., Holmes E.C., Gould E.A., de Lamballerie X. Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy. Virology 2007, 361(1):80-92.
12. Gromowski G.D., Barrett A.D. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 2007, 366(2):349-360.
13. Hamill S.J., Cota E., Chothia C., Clarke J. Conservation of folding and stability within a protein family: the tyrosine corner as an evolutionary cul-de-sac. J. Mol. Biol. 2000, 295(3):641-649.
14. Hemmingsen J.M., Gernert K.M., Richardson J.S., Richardson D.C. The tyrosine corner: a feature of most Greek key beta-barrel proteins. Protein Sci. 1994, 3(11):1927-1937.
15. Hogrefe, H. H., Cline, J., Youngblood, G. L., and Allen, R. M. (2002). Creating randomized amino acid libraries with the QuikChange Multi Site-Directed Mutagenesis Kit. Biotechniques 33(5), 1158-60, 1162, 1164-5.
16. Hung J.J., Hsieh M.T., Young M.J., Kao C.L., King C.C., Chang W. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 2004, 78(1):378-388.
17. Hurrelbrink R.J., McMinn P.C. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J. Virol. 2001, 75(16):7692-7702.
18. Kanai R., Kar K., Anthony K., Gould L.H., Ledizet M., Fikrig E., Marasco W.A., Koski R.A., Modis Y. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 2006, 80(22):11000-11008.
19. Kinney R.M., Huang C.Y., Whiteman M.C., Bowen R.A., Langevin S.A., Miller B.R., Brault A.C. Avian virulence and thermostable replication of the North American strain of West Nile virus. J. Gen. Virol. 2006, 87(Pt 12):3611-3622.
20. Lee E., Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 2000, 74(19):8867-8875.
21. Lee J.W., Chu J.J., Ng M.L. Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin. J. Biol. Chem. 2006, 281(3):1352-1360.
22. Li L., Barrett A.D., Beasley D.W. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 2005, 335(1):99-105.
23. Lisova O., Hardy F., Petit V., Bedouelle H. Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus. J. Gen. Virol. 2007, 88(Pt 9):2387-2397.
24. Mandl C.W., Allison S.L., Holzmann H., Meixner T., Heinz F.X. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J. Virol. 2000, 74(20):9601-9609.
25. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U S A 2003, 100(12):6986-6991.
26. Mukhopadhyay S., Kim B.S., Chipman P.R., Rossmann M.G., Kuhn R.J. Structure of West Nile virus. Science 2003, 302(5643):248.
27. Nicaise M., Valerio-Lepiniec M., Izadi-Pruneyre N., Adjadj E., Minard P., Desmadril M. Role of the tyrosine corner motif in the stability of neocarzinostatin. Protein Eng. 2003, 16(10):733-738.
28. Nybakken G.E., Nelson C.A., Chen B.R., Diamond M.S., Fremont D.H. Crystal structure of the West Nile virus envelope glycoprotein. J Virol 2006, 80(23):11467-11474.
29. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 2005, 437(7059):764-769.
30. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D.H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005, 11(5):522-530.
31. Pattnaik P., Babu J.P., Verma S.K., Tak V., Rao P.V. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2007, 846(1-2):184-194.
32. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995, 375(6529):291-298.
33. Roehrig J.T. Antigenic structure of flavivirus proteins. Adv. Virus Res. 2003, 59:141-175.
34. Sanchez M.D., Pierson T.C., McAllister D., Hanna S.L., Puffer B.A., Valentine L.E., Murtadha M.M., Hoxie J.A., Doms R.W. Characterization of neutralizing antibodies to West Nile virus. Virology 2005, 336(1):70-82.
35. Volk D.E., Beasley D.W., Kallick D.A., Holbrook M.R., Barrett A.D., Gorenstein D.G. Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J. Biol. Chem. 2004, 279(37):38755-38761.
36. Volk D.E., Lee Y.C., Li X., Thiviyanathan V., Gromowski G.D., Li L., Lamb A.R., Beasley D.W., Barrett A.D., Gorenstein D.G. Solution structure of the envelope protein domain III of dengue-4 virus. Virology 2007, 364(1):147-154.
37. Volk D.E., May F.J., Gandham S.H., Anderson A., Von Lindern J.J., Beasley D.W., Barrett A.D., Gorenstein D.G. Structure of yellow fever virus envelope protein domain III. Virology 2009, 394(1):12-18.
38. Wu K.P., Wu C.W., Tsao Y.P., Kuo T.W., Lou Y.C., Lin C.W., Wu S.C., Cheng J.W. Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J. Biol. Chem. 2003, 278(46):46007-46013.
39. Yu S., Wuu A., Basu R., Holbrook M.R., Barrett A.D., Lee J.C. Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses. Biochemistry 2004, 43(28):9168-9176.
40. Zhang S., Li L., Woodson S.E., Huang C.Y., Kinney R.M., Barrett A.D., Beasley D.W. A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology 2006, 353(1):35-40.
41. Zhang S., Vogt M.R., Oliphant T., Engle M., Bovshik E.I., Diamond M.S., Beasley D.W. Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. J. Infect. Dis. 2009, 200(2):202-205.